Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Dendreon posts 4th-quarter loss versus year-ago profit
Reuters
Monday, February 25, 2013 - 10:19am
tags:
earnings, Dendreon
SPPI Beats in 4Q on Higher Sales
Yahoo/Zacks
Monday, February 25, 2013 - 10:17am
tags:
earnings, Spectrum Pharmaceuticals
Blood Drug Woes Could Weigh on FDA and its Approval of New, Copycat Biologic Medicines
Forbes
Monday, February 25, 2013 - 10:13am
tags:
FDA, drug approvals, Omontys, follow-on biologics, Affymax
Elan Armed With Biogen Billions Hunts for Deals: Real M&A
Bloomberg
Monday, February 25, 2013 - 10:12am
tags:
Elan, Biogen Idec, M&A
Cubist Announces Exclusive Option to Acquire Adynxx
Yahoo
Monday, February 25, 2013 - 10:10am
tags:
Cubist Pharmaceuticals, Adynxx, AYX1, M&A
Dynavax May Seek Quick Re-File of HepB Vax Following FDA Rejection
TheStreet.com
Monday, February 25, 2013 - 10:08am
tags:
Dynavax, FDA, vaccines, Heplisav, hepatitis B
Dynavax slides as FDA rejects adult hep B vaccine
Reuters
Monday, February 25, 2013 - 10:06am
tags:
FDA, hepatitis B, vaccines, Dynavax, Heplisav
Warner Chilcott says U.S. elects not to intervene in qui tam action at this time
Yahoo/Fly on the Wall
Monday, February 25, 2013 - 9:58am
tags:
Warner Chilcott, False Claims Act, Atelvia, Actonel
Endo Health new CEO suggests near-term sale unlikely, says Wells Fargo
The Fly on the Wall
Monday, February 25, 2013 - 9:53am
tags:
Endo Health Solutions, M&A, Pharma CEOs, Rajiv De Silva
INSIGHT-Cancer drugs proving worth earlier in testing
Reuters
Monday, February 25, 2013 - 9:52am
tags:
cancer, FDA
Down 85%! Why Affymax Is Getting Crushed This Morning
Motley Fool
Monday, February 25, 2013 - 9:50am
tags:
Affymax, Omontys, dialysis, anemia, recalls, Takeda
Johnson & Johnson expect to incur $100M charge to net income in Q1
The Fly on the Wall
Monday, February 25, 2013 - 9:48am
tags:
JNJ, guidance
Diagnosis And Treatment Of Disease With Radiotherapies May Prove Profitable In 2013
Seeking Alpha
Monday, February 25, 2013 - 9:47am
tags:
radiotherapy, Advanced Medical Isotope, GE, Eli Lilly, Merck
Pharma Pipeline Transparency Makes It Hard To Hide Negative Clinical Trials
Forbes
Monday, February 25, 2013 - 9:45am
tags:
clinical trials
Strides Arcolab looks to sell stake worth Rs 4,885 cr
Business Standard, India
Sunday, February 24, 2013 - 2:53pm
tags:
Strides Arcolab
How Valeant became Canada's hottest stock
Globe and Mail, Canada
Sunday, February 24, 2013 - 2:51pm
tags:
Valeant Pharmaceuticals
Immune Initiates Bertilimumab Phase II Clinical Trial in Ulcerative Colitis
PharmaLive
Sunday, February 24, 2013 - 2:40pm
tags:
Immune Pharmaceuticals, bertilimumab, ulcerative colitis
Why Buyers Sent Infinity 550% Higher In The Last Year
Proactive Investors
Sunday, February 24, 2013 - 2:38pm
tags:
Infinity Pharmaceuticals
Dendreon Earnings: An Early Look
Motley Fool
Sunday, February 24, 2013 - 2:36pm
tags:
Dendreon
3 Humongous Health-Care Stocks This Week
Motley Fool
Sunday, February 24, 2013 - 2:36pm
tags:
Infinity Pharmaceuticals, Celldex, Questcor Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.